• L'acide acétylsalicylique (AAS) n'est plus recommandé en prévention primaire chez les
personnes ne présentant aucun antécédent de maladie cardiovasculaire, d'accident …

This set of recommendations is intended to provide guidance for the use of ASA for primary
prevention of vascular events. Additionally, the guideline comments on secondary stroke …

Low-dose acetylsalicylic acid (ASA) for prevention of cardiovascular disease (CVD),
including myocardial infarction (MI) and stroke, is likely something that comes up frequently …

Acetylsalicylic acid (ASA) alone (at least 30 mg per day) in post-cerebral ischaemia patients
reduces the relative risk of further vascular events by 13% compared with placebo. A meta …

Acetylsalicylsäure zur Primär- und Sekundärprävention vaskulärer Erkrankungen Page 1
Wissenschaftlicher Beirat M. Hallek, Köln K. Kochsiek, Würzburg W. Lehmacher, Köln P …

Conclusion Cette méta-analyse confirme les données connues des études évaluant les
effets de l'administration d'acide acétylsalicylique à différentes doses (de 100 mg tous les …

Results Data for 438 of the 7054 patients initially recruited were deemed unreliable;
intention to treat (ITT) analyses included 6602 patients. Also, 42 patients were lost to follow …

Objectives: Discontinuation of low-dose acetylsalicylic acid (ASA) therapy may increase the
risk of ischemic events. This study evaluated the risk of ischemic stroke (IS) and TIA after low …

In the early 1980s, investigators from Harvard's Brigham and Women's Hospital in Boston
designed the Physicians' Health Study, the first randomized controlled trial to investigate …

Numerous studies have investigated use of acetylsalicylic acid (ASA) for prevention of
cardiovascular deaths. The vast majority of the work in this area has focused on secondary …